WHO ICTRP trial
Herbal Compound In Irritable Bowel Syndrome (IBS)
CTRI/2022/07/044150 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/07/044150 |
|---|---|
| Public title | Herbal Compound In Irritable Bowel Syndrome (IBS) |
| Scientific title | Clinical Efficacy Of Herbal Compound In Irritable Bowel Syndrome |
| Primary sponsor | Himalayiya Ayurvedic Medical College and Hospital Dehradun |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: K928- Other specified diseases of the digestive system |
| Registration date | Jul 19, 2022 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: